{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:27:34Z","timestamp":1784762854512,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T00:00:00Z","timestamp":1450742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T00:00:00Z","timestamp":1450742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cardio-renal fibrosis plays key roles in heart failure and chronic kidney disease. We sought to determine the effects of renal denervation (RDN) on cardiac and renal fibrosis in rats with isoproterenol induced cardiomyopathy. Sixty male Sprague Dawley rats were randomly assigned to Control (n\u2009=\u200910) and isoproterenol (ISO)-induced cardiomyopathy group (n\u2009=\u200950). At week 5, 31 survival ISO-induced cardiomyopathy rats were randomized to RDN (n\u2009=\u200915) and Sham group (n\u2009=\u200916). Compared with Control group, ejection fraction was decreased, diastolic interventricular septal thickness and left atrial dimension were increased in ISO-induced cardiomyopathy group at 5 week. After 10 weeks, cardio-renal pathophysiologic results demonstrated that the collagen volume fraction of left atrio-ventricular and kidney tissues reduced significantly in RDN group compared with Sham group. Moreover the pro-fibrosis factors (TGF-\u03b21, MMP2 and Collagen I), inflammatory cytokines (CRP and TNF-\u03b1) and collagen synthesis biomarkers (PICP, PINP and PIIINP) concentration significantly decreased in RDN group. Compared with Sham group, RDN group showed that release of noradrenaline and aldosterone were reduced, angiotensin-converting enzyme (ACE)\/angiotensin II (Ang II)\/angiotensin II type-1 receptor (AT<jats:sub>1<\/jats:sub>R) axis was downregulated. Meanwhile, angiotensin-converting enzyme 2 (ACE2)\/angiotensin-1-7 (Ang-(1-7))\/mas receptor (Mas-R) axis was upregulated. RDN inhibits cardio-renal fibrogenesis through multiple pathways, including reducing SNS over-activity, rebalancing RAAS axis.<\/jats:p>","DOI":"10.1038\/srep18582","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T11:10:51Z","timestamp":1450782651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Renal Denervation Findings on Cardiac and Renal Fibrosis in Rats with Isoproterenol Induced Cardiomyopathy"],"prefix":"10.1038","volume":"5","author":[{"given":"Qian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengchan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dasheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijun","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,22]]},"reference":[{"key":"BFsrep18582_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1056\/NEJMc1504848","volume":"373","author":"DC Rockey","year":"2015","unstructured":"Rockey, D. C., Bell, P. D. & Hill, J. A. Fibrosis\u2013A Common Pathway to Organ Injury and Failure. N Engl J Med 373, 96, 10.1056\/NEJMc1504848 (2015).","journal-title":"N Engl J Med"},{"key":"BFsrep18582_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0079-6107(03)00012-9","volume":"82","author":"U Schotten","year":"2003","unstructured":"Schotten, U., Neuberger, H. R. & Allessie, M. A. The role of atrial dilatation in the domestication of atrial fibrillation. Prog Biophys Mol Biol 82, 151\u2013162 (2003).","journal-title":"Prog Biophys Mol Biol"},{"key":"BFsrep18582_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/01.CIR.100.1.87","volume":"100","author":"D Li","year":"1999","unstructured":"Li, D., Fareh, S., Leung, T. K. & Nattel, S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 100, 87\u201395 (1999).","journal-title":"Circulation"},{"key":"BFsrep18582_CR4","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jacc.2010.06.062","volume":"57","author":"L Iles","year":"2011","unstructured":"Iles, L. et al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol 57, 821\u2013828, 10.1016\/j.jacc.2010.06.062 (2011).","journal-title":"J Am Coll Cardiol"},{"key":"BFsrep18582_CR5","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","volume":"342","author":"P Spirito","year":"2000","unstructured":"Spirito, P. et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342, 1778\u20131785, 10.1056\/NEJM200006153422403 (2000).","journal-title":"N Engl J Med"},{"key":"BFsrep18582_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000349968","volume":"182","author":"DN Cruz","year":"2013","unstructured":"Cruz, D. N. et al. Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 182, 117\u2013136, 10.1159\/000349968 (2013).","journal-title":"Contrib Nephrol"},{"key":"BFsrep18582_CR7","doi-asserted-by":"crossref","unstructured":"Rodriguez-Iturbe, B., Johnson, R. J. & Herrera-Acosta, J. Tubulointerstitial damage and progression of renal failure. Kidney Int Supplement, S82\u201386, 10.1111\/j.1523-1755.2005.09915.x (2005).","DOI":"10.1111\/j.1523-1755.2005.09915.x"},{"key":"BFsrep18582_CR8","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","volume":"376","author":"HTNI Symplicity","year":"2010","unstructured":"Symplicity, H. T. N. I. et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376, 1903\u20131909, 10.1016\/S0140-6736(10)62039-9 (2010).","journal-title":"Lancet"},{"key":"BFsrep18582_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11886-012-0258-x","volume":"14","author":"PA Sobotka","year":"2012","unstructured":"Sobotka, P. A., Krum, H., Bohm, M., Francis, D. P. & Schlaich, M. P. The role of renal denervation in the treatment of heart failure. Curr Cardiol Rep 14, 285\u2013292, 10.1007\/s11886-012-0258-x (2012).","journal-title":"Curr Cardiol Rep"},{"key":"BFsrep18582_CR10","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.jacc.2013.05.068","volume":"62","author":"MA Scherlag","year":"2013","unstructured":"Scherlag, M. A. & Scherlag, B. J. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol 62, 1129\u20131130, 10.1016\/j.jacc.2013.05.068 (2013).","journal-title":"J Am Coll Cardiol"},{"key":"BFsrep18582_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00392-011-0365-5","volume":"101","author":"C Ukena","year":"2012","unstructured":"Ukena, C. et al. Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol 101, 63\u201367, 10.1007\/s00392-011-0365-5 (2012).","journal-title":"Clin Res Cardiol"},{"key":"BFsrep18582_CR12","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/eurheartj\/eht200","volume":"34","author":"MG Kiuchi","year":"2013","unstructured":"Kiuchi, M. G. et al. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension. Eur Heart J 34, 2114\u20132121, 10.1093\/eurheartj\/eht200 (2013).","journal-title":"Eur Heart J"},{"key":"BFsrep18582_CR13","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/01.ASN.0000113320.57127.B9","volume":"15","author":"HA Koomans","year":"2004","unstructured":"Koomans, H. A., Blankestijn, P. J. & Joles, J. A. Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol 15, 524\u2013537 (2004).","journal-title":"J Am Soc Nephrol"},{"key":"BFsrep18582_CR14","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/hc1102.105261","volume":"105","author":"C Zoccali","year":"2002","unstructured":"Zoccali, C. et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 105, 1354\u20131359 (2002).","journal-title":"Circulation"},{"key":"BFsrep18582_CR15","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1161\/01.CIR.98.23.2621","volume":"98","author":"HC Yu","year":"1998","unstructured":"Yu, H. C. et al. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 98, 2621\u20132628 (1998).","journal-title":"Circulation"},{"key":"BFsrep18582_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/jpi.12154","volume":"57","author":"F Simko","year":"2014","unstructured":"Simko, F. et al. Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol-induced heart failure. J Pineal Res 57, 177\u2013184, 10.1111\/jpi.12154 (2014).","journal-title":"J Pineal Res"},{"key":"BFsrep18582_CR17","doi-asserted-by":"crossref","unstructured":"Li, Z. Z. et al. Renal sympathetic denervation improves cardiac dysfunction in rats with chronic pressure overload. Physiol Res (2015).[in press].","DOI":"10.33549\/physiolres.932912"},{"key":"BFsrep18582_CR18","first-page":"197","volume":"59","author":"T Zahajszky","year":"1982","unstructured":"Zahajszky, T., Fejes-Toth, G. & Filep, J. Effect of isoproterenol on renal function. Acta physiologica Hungarica 59, 197\u2013202 (1982).","journal-title":"Acta physiologica Hungarica"},{"key":"BFsrep18582_CR19","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/0002-8703(61)90372-6","volume":"62","author":"H Sandler","year":"1961","unstructured":"Sandler, H., Dodge, H. T. & Murdaugh, H. V., Jr. Effects of isoproterenol on cardiac output and renal function in congestive heart failure. Am Heart J 62, 643\u2013651 (1961).","journal-title":"Am Heart J"},{"key":"BFsrep18582_CR20","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/CIRCULATIONAHA.111.089409","volume":"126","author":"TC Wong","year":"2012","unstructured":"Wong, T. C. et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 126, 1206\u20131216, 10.1161\/CIRCULATIONAHA.111.089409 (2012).","journal-title":"Circulation"},{"key":"BFsrep18582_CR21","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/ajh\/hpu123","volume":"28","author":"D Linz","year":"2015","unstructured":"Linz, D. et al. Progression of kidney injury and cardiac remodeling in obese spontaneously hypertensive rats: the role of renal sympathetic innervation. Am J Hypertens 28, 256\u2013265, 10.1093\/ajh\/hpu123 (2015).","journal-title":"Am J Hypertens"},{"key":"BFsrep18582_CR22","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.freeradbiomed.2014.05.024","volume":"73","author":"E Rizzi","year":"2014","unstructured":"Rizzi, E. et al. beta1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity and improve renovascular hypertension-induced cardiac hypertrophy. Free Radic Biol Med 73, 308\u2013317, 10.1016\/j.freeradbiomed.2014.05.024 (2014).","journal-title":"Free Radic Biol Med"},{"key":"BFsrep18582_CR23","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/S0735-1097(97)00012-0","volume":"29","author":"RN Doughty","year":"1997","unstructured":"Doughty, R. N., Whalley, G. A., Gamble, G., MacMahon, S. & Sharpe, N. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. J Am Coll Cardiol 29, 1060\u20131066 (1997).","journal-title":"J Am Coll Cardiol"},{"key":"BFsrep18582_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1161\/01.CIR.96.1.183","volume":"96","author":"S Basu","year":"1997","unstructured":"Basu, S. et al. Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial. Circulation 96, 183\u2013191 (1997).","journal-title":"Circulation"},{"key":"BFsrep18582_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1681\/ASN.2012070678","volume":"24","author":"J Kim","year":"2013","unstructured":"Kim, J. & Padanilam, B. J. Renal nerves drive interstitial fibrogenesis in obstructive nephropathy. J Am Soc Nephrol 24, 229\u2013242, 10.1681\/ASN.2012070678 (2013).","journal-title":"J Am Soc Nephrol"},{"key":"BFsrep18582_CR26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nrd873","volume":"1","author":"MA Zaman","year":"2002","unstructured":"Zaman, M. A., Oparil, S. & Calhoun, D. A. Drugs targeting the renin-angiotensin-aldosterone system. Nat Rev Drug Discov 1, 621\u2013636, 10.1038\/nrd873 (2002).","journal-title":"Nat Rev Drug Discov"},{"key":"BFsrep18582_CR27","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1161\/01.cir.0000017264.66561.3d","volume":"105","author":"J Diez","year":"2002","unstructured":"Diez, J. Losartan-Dependent Regression of Myocardial Fibrosis Is Associated With Reduction of Left Ventricular Chamber Stiffness in Hypertensive Patients. Circulation 105, 2512\u20132517, 10.1161\/01.cir.0000017264.66561.3d (2002).","journal-title":"Circulation"},{"key":"BFsrep18582_CR28","doi-asserted-by":"publisher","first-page":"H2487","DOI":"10.1152\/ajpheart.00462.2004","volume":"287","author":"K Funabiki","year":"2004","unstructured":"Funabiki, K. et al. Combined angiotensin receptor blocker and ACE inhibitor on myocardial fibrosis and left ventricular stiffness in dogs with heart failure. American journal of physiology. Am J Physiol Heart Circ Physiol 287, H2487\u20132492, 10.1152\/ajpheart.00462.2004 (2004).","journal-title":"American journal of physiology. Am J Physiol Heart Circ Physiol"},{"key":"BFsrep18582_CR29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/01.HYP.30.3.535","volume":"30","author":"CM Ferrario","year":"1997","unstructured":"Ferrario, C. M., Chappell, M. C., Tallant, E. A., Brosnihan, K. B. & Diz, D. I. Counterregulatory actions of angiotensin-(1-7). Hypertension 30, 535\u2013541 (1997).","journal-title":"Hypertension"},{"key":"BFsrep18582_CR30","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/hr.2009.74","volume":"32","author":"M Iwai","year":"2009","unstructured":"Iwai, M. & Horiuchi, M. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens Res 32, 533\u2013536, 10.1038\/hr.2009.74 (2009).","journal-title":"Hypertens Res"},{"key":"BFsrep18582_CR31","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","volume":"122","author":"J Zhong","year":"2010","unstructured":"Zhong, J. et al. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis and cardiac dysfunction. Circulation 122, 717\u2013728 (2010).","journal-title":"Circulation"},{"key":"BFsrep18582_CR32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3109\/10715762.2011.560149","volume":"45","author":"AP Lakshmanan","year":"2011","unstructured":"Lakshmanan, A. P. et al. Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1\u20137) mas receptor expression associated with its PPAR-\u03b3 agonist action. Free Radic Res 45, 575\u2013584 (2011).","journal-title":"Free Radic Res"},{"key":"BFsrep18582_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jchf.2014.08.002","volume":"3","author":"L Calvier","year":"2015","unstructured":"Calvier, L. et al. The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries. JACC. Heart failure 3, 59\u201367, 10.1016\/j.jchf.2014.08.002 (2015).","journal-title":"JACC. Heart failure"},{"key":"BFsrep18582_CR34","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.cardiores.2004.04.030","volume":"63","author":"S Rosenkranz","year":"2004","unstructured":"Rosenkranz, S. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res 63, 423\u2013432, 10.1016\/j.cardiores.2004.04.030 (2004).","journal-title":"Cardiovasc Res"},{"key":"BFsrep18582_CR35","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/hmg\/ddt514","volume":"23","author":"MJ Acuna","year":"2014","unstructured":"Acuna, M. J. et al. Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-beta signalling. Hum Mol Genet 23, 1237\u20131249, 10.1093\/hmg\/ddt514 (2014).","journal-title":"Hum Mol Genet"},{"key":"BFsrep18582_CR36","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/sj.ki.5002373","volume":"72","author":"MJ Soler","year":"2007","unstructured":"Soler, M. J. et al. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int 72, 614\u2013623, 10.1038\/sj.ki.5002373 (2007).","journal-title":"Kidney Int"},{"key":"BFsrep18582_CR37","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1161\/01.HYP.0000121462.27393.f6","volume":"43","author":"JG Modrall","year":"2004","unstructured":"Modrall, J. G. et al. Depletion of tissue angiotensin-converting enzyme differentially influences the intrarenal and urinary expression of angiotensin peptides. Hypertension 43, 849\u2013853, 10.1161\/01.HYP.0000121462.27393.f6 (2004).","journal-title":"Hypertension"},{"key":"BFsrep18582_CR38","doi-asserted-by":"publisher","first-page":"F579","DOI":"10.1152\/ajprenal.00548.2009","volume":"298","author":"J Zhang","year":"2010","unstructured":"Zhang, J., Noble, N. A., Border, W. A. & Huang, Y. Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis. Am J Physiol Renal Physiol 298, F579\u2013588, 10.1152\/ajprenal.00548.2009 (2010).","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFsrep18582_CR39","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1042\/CS20140432","volume":"128","author":"AS Brem","year":"2015","unstructured":"Brem, A. S. & Gong, R. Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease. Clin Sci 128, 527\u2013535, 10.1042\/CS20140432 (2015).","journal-title":"Clin Sci"},{"key":"BFsrep18582_CR40","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1159\/000430310","volume":"36","author":"MD Cezar","year":"2015","unstructured":"Cezar, M. D. et al. Early Spironolactone Treatment Attenuates Heart Failure Development by Improving Myocardial Function and Reducing Fibrosis in Spontaneously Hypertensive Rats. Cell Physiol Biochem 36, 1453\u20131466, 10.1159\/000430310 (2015).","journal-title":"Cell Physiol Biochem"},{"key":"BFsrep18582_CR41","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","volume":"63","author":"ER Blasi","year":"2003","unstructured":"Blasi, E. R. et al. Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int 63, 1791\u20131800, 10.1046\/j.1523-1755.2003.00929.x (2003).","journal-title":"Kidney Int"},{"key":"BFsrep18582_CR42","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/path.4493","volume":"235","author":"AL Bates","year":"2015","unstructured":"Bates, A. L. et al. Stromal matrix metalloproteinase 2 regulates collagen expression and promotes the outgrowth of experimental metastases. J Pathol 235, 773\u2013783, 10.1002\/path.4493 (2015).","journal-title":"J Pathol"},{"key":"BFsrep18582_CR43","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1161\/01.CIR.0000020689.12472.E0","volume":"106","author":"F Kuwahara","year":"2002","unstructured":"Kuwahara, F. et al. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 106, 130\u2013135 (2002).","journal-title":"Circulation"},{"key":"BFsrep18582_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000340033","volume":"36","author":"FJ Therrien","year":"2012","unstructured":"Therrien, F. J., Agharazii, M., Lebel, M. & Lariviere, R. Neutralization of tumor necrosis factor-alpha reduces renal fibrosis and hypertension in rats with renal failure. Am J Nephrol 36, 151\u2013161, 10.1159\/000340033 (2012).","journal-title":"Am J Nephrol"},{"key":"BFsrep18582_CR45","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1161\/hc4901.101760","volume":"104","author":"MK Chung","year":"2001","unstructured":"Chung, M. K. et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104, 2886\u20132891 (2001).","journal-title":"Circulation"},{"key":"BFsrep18582_CR46","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s00395-007-0673-0","volume":"102","author":"D Westermann","year":"2007","unstructured":"Westermann, D. et al. Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol 102, 500\u2013507, 10.1007\/s00395-007-0673-0 (2007).","journal-title":"Basic Res Cardiol"},{"key":"BFsrep18582_CR47","doi-asserted-by":"crossref","unstructured":"Dorr, O. et al. Influence of Renal Sympathetic Denervation on Cardiac Extracellular Matrix Turnover and Cardiac Fibrosis. Am J Hypertens, 10.1093\/ajh\/hpv020 (2015).[in press].","DOI":"10.1093\/ajh\/hpv020"},{"key":"BFsrep18582_CR48","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/01.CIR.98.6.535","volume":"98","author":"C Laviades","year":"1998","unstructured":"Laviades, C. et al. Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation 98, 535\u2013540 (1998).","journal-title":"Circulation"},{"key":"BFsrep18582_CR49","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0033-0620(05)80020-9","volume":"37","author":"IH Zucker","year":"1995","unstructured":"Zucker, I. H., Wang, W., Brandle, M., Schultz, H. D. & Patel, K. P. Neural regulation of sympathetic nerve activity in heart failure. Prog Cardiovasc Dis 37, 397\u2013414 (1995).","journal-title":"Prog Cardiovasc Dis"},{"key":"BFsrep18582_CR50","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1056\/NEJM199212313272704","volume":"327","author":"RL Converse Jr.","year":"1992","unstructured":"Converse, R. L., Jr. et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327, 1912\u20131918, 10.1056\/NEJM199212313272704 (1992).","journal-title":"N Engl J Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep18582","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep18582.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep18582.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:58:35Z","timestamp":1672966715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep18582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,22]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,11,22]]}},"alternative-id":["BFsrep18582"],"URL":"https:\/\/doi.org\/10.1038\/srep18582","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,22]]},"assertion":[{"value":"16 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18582"}}